Related references
Note: Only part of the references are listed.Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
Emily J. Faivre et al.
NATURE (2020)
Impaired cell fate through gain-of-function mutations in a chromatin reader
Liling Wan et al.
NATURE (2020)
Invited Review: Emerging functions of histone H3 mutations in paediatric diffuse high-grade gliomas
L. H. Kasper et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2020)
Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation
David Castel et al.
ACTA NEUROPATHOLOGICA (2020)
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
Jianhui Ma et al.
CANCER CELL (2019)
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas
Brian Krug et al.
CANCER CELL (2019)
Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease
J. Qi et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Understanding histone H3 lysine 36 methylation and its deregulation in disease
Jie Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Coupling Fluorescence-Activated Cell Sorting and Targeted Analysis of Histone Modification Profiles in Primary Human Leukocytes
Jeannie M. Camarillo et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2019)
Selective binding of the PHD6 finger of MLL4 to histone H4K16ac links MLL4 and MOF
Yi Zhang et al.
NATURE COMMUNICATIONS (2019)
H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3 Histone Tags Suggest Distinct Regulatory Evolution of Open and Condensed Chromatin Landmarks
Anna A. Igolkina et al.
CELLS (2019)
Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG
Jamie N. Anastas et al.
CANCER CELL (2019)
Histone Variant and Cell Context Determine H3K27M Reprogramming of the Enhancer Landscape and Oncogenic State
Surya Nagaraja et al.
MOLECULAR CELL (2019)
H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo
Andre B. Silveira et al.
ACTA NEUROPATHOLOGICA (2019)
Targeting Epigenetics in Cancer
Richard L. Bennett et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
Dual HDAC and PI3K Inhibition Abrogates NF kappa B- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas
Sharmistha Pal et al.
CANCER RESEARCH (2018)
High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2
Nathan P. Coussens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening
Rukang Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
H3K9me3 and H4K20me3 represent the epigenetic landscape for 53BP1 binding to DNA lesions
Alena Svobodova Kovarikova et al.
AGING-US (2018)
Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes
Tina Huang et al.
Oncotarget (2018)
Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma
James M. Stafford et al.
SCIENCE ADVANCES (2018)
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
Andrea Piunti et al.
NATURE MEDICINE (2017)
Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG)
Ho-Shin Gwak et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
Alan Mackay et al.
CANCER CELL (2017)
Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma
Surya Nagaraja et al.
CANCER CELL (2017)
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Dominik Sturm et al.
CELL (2016)
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
David Castel et al.
ACTA NEUROPATHOLOGICA (2015)
DIPG in children - what can we learn from the past?
Magimairajan Issai Vanan et al.
FRONTIERS IN ONCOLOGY (2015)
Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes
Amanda M. Saratsis et al.
ACTA NEUROPATHOLOGICA (2014)
Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications
Pawel Buczkowicz et al.
ACTA NEUROPATHOLOGICA (2014)
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas
Sriram Venneti et al.
ACTA NEUROPATHOLOGICA (2014)
Affinity Map of Bromodomain Protein 4 ( BRD4) Interactions with the Histone H4 Tail and the Small Molecule Inhibitor JQ1
Marie Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
Rintaro Hashizume et al.
NATURE MEDICINE (2014)
Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling
Hans-Martin Herz et al.
SCIENCE (2014)
\ Bromodomain and Extraterminal Domain Inhibitors (BETi) for Cancer Therapy: Chemical Modulation of Chromatin Structure
Jun Qi
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Evaluation of Histone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 in H3F3A K27M Mutant Glioblastomas
Sriram Venneti et al.
BRAIN PATHOLOGY (2013)
Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
Sebastian Bender et al.
CANCER CELL (2013)
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
Kui-Ming Chan et al.
GENES & DEVELOPMENT (2013)
Chromatin proteins and modifications as drug targets
Kristian Helin et al.
NATURE (2013)
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Peter W. Lewis et al.
SCIENCE (2013)
The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas
Tina Dasgupta et al.
FRONTIERS IN ONCOLOGY (2013)
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
Dong-Anh Khuong-Quang et al.
ACTA NEUROPATHOLOGICA (2012)
Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment
Rintaro Hashizume et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
H3K36 Methylation Antagonizes PRC2-mediated H3K27 Methylation
Wen Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non-Small-Cell Lung Cancer
Qing Zhou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Histone Methylation by PRC2 Is Inhibited by Active Chromatin Marks
Frank W. Schmitges et al.
MOLECULAR CELL (2011)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Role of the polycomb protein EED in the propagation of repressive histone marks
Raphael Margueron et al.
NATURE (2009)
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Jeffrey A. Simon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
High-resolution profiling of histone methylations in the human genome
Artern Barski et al.
CELL (2007)
Chemical derivatization of histones for facilitated analysis by mass spectrometry
Benjamin A. Garcia et al.
NATURE PROTOCOLS (2007)
Clustered DNA damage induced by radiation in human fibroblasts (HF19), hamster (V79-4) cells and plasmid DNA is revealed as Fpg and Nth sensitive sites
M Gulston et al.
NUCLEIC ACIDS RESEARCH (2002)